CVKD stock news
This page provides real-time market news, earnings updates, and company announcements related to Cadrenal Therapeutics, Inc. (CVKD).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-06 06:23 EST
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
Finviz2026-02-24 13:33:09
Cadrenal Therapeutics Inc recently received approval from the U.S. Food and Drug Administration (FDA) to hold an end-of-Phase II clinical trial meeting.
老虎证券2026-02-24 13:55:32
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Finviz2026-03-02 13:03:56
CVKD stock chart
CVKD stock detailsCVKD stock price change
On the last trading day, CVKD stock closed at 8.30 USD, with a price change of 2.09% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more